High Accuracy & Reliability
Utilizes advanced immunoassay technology for detecting Influenza A and B antigens with high sensitivity (≥90%) and specificity (≥95%).
Minimizes false positives/negatives, ensuring reliable diagnostic results.
Fast & Easy Testing
Provides results in 10–15 minutes, enabling quick decision-making for treatment.
Simple two-step procedure: Add sample, read results—no complex equipment needed.
Multiple Sample Compatibility
Works with nasopharyngeal swabs, throat swabs, or nasal aspirates, offering flexibility in sample collection.
Includes buffer solution for optimal sample preparation.
Clear & User-Friendly Design
Visual readout (colored lines) for easy interpretation—no external devices required.
Built-in control line ensures test validity and proper performance.
Compact & Portable
Lightweight and ideal for point-of-care (POC) settings, including clinics, ERs, pharmacies, and home use.
No refrigeration needed—stable at room temperature (2–30°C).
Cost-Effective & Efficient
Eliminates the need for lab processing, reducing time and costs compared to PCR tests.
Enables early detection and isolation to prevent outbreaks.
Wide Clinical Applications
Supports early diagnosis during flu season, aiding in timely antiviral treatment.
Helps differentiate between Influenza A and B, guiding appropriate therapy.
Regulatory Approvals
CE Marked, FDA-Cleared (for some tests), and compliant with global quality standards.
